Member Info for Saintsmith

Hopefully with the increased S & S it will now be relabelled and relaunched for public use ..

Hi Wilson .
You are correct , no links between us anymore . There was a manufacturing agreement for Ygen to make our tests but It never came to fruition .

Ygen are showing the markets a post covid plan regarding us deals with oncology and NIPT (pre natal testing ).
This is what Novacyt needs to do . Apologies for posting here although I think we have a few joint holders and comparisons with EKF and YGEN exist with Novacyt.
That and the fact NCYT are currently giving us Feck all to discuss here .

Exactly hamsters a good non covid plan going forward .
Any ideas who the big US contract may be with @stas ?

This is great news. Entering the oncology market and prenatal testing in the US.

Meanwhile on a board where the company actually RNS . Ygen is partnering with EKF.
EKF has been compared to Novacyt many times on this board in terms of valuations .
Come on Novacyt . Let us know what you are up to .

Yourgene Health plc

("Yourgene" or the "Company")



US partnership with EKF Diagnostics for NIPT and additional genomic tests

Collaboration with EKF Diagnostics to use its accredited US laboratories for NIPT and Oncology testing



Manchester, UK - 18 January 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has signed a strategic partnership agreement with EKF Diagnostics Holdings plc ("EKF", AIM: EKF), a point-of-care business with accredited laboratory testing capabilities in the US, whereby EKF will offer an NIPT service to the US market based on Yourgene's proprietary non-invasive prenatal technology for an initial 5-year period.

This is great news .

Yourgene Health plc

("Yourgene" or the "Company")



US partnership with EKF Diagnostics for NIPT and additional genomic tests

Collaboration with EKF Diagnostics to use its accredited US laboratories for NIPT and Oncology testing



Manchester, UK - 18 January 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it has signed a strategic partnership agreement with EKF Diagnostics Holdings plc ("EKF", AIM: EKF), a point-of-care business with accredited laboratory testing capabilities in the US, whereby EKF will offer an NIPT service to the US market based on Yourgene's proprietary non-invasive prenatal technology for an initial 5-year period.

For everyone feeling deflated due to the lack of info I suggest rewatching this video released last November .
People keep talking about market not having plans after covid and only valuing us as a covid stock .

In this video we talk about talking respiratory and transplantation markets .
Veterinarian testing.
Human pathogen testing for future yet unknown viruses.
Oncology .
Sickle cell disease testing and many others .
Don’t forget our 10 minute test too .
It’s easy to get annoyed with our lack of communication and depleting share price but keep the faith guys and girls .

https://youtu.be/6V-etfFdFJM

Maybe a good time to top up in anticipation of results .
Never underestimate the power of a good RNS to boost the SP, yourgene up over 4% now .
Unfortunately our BOD seem happy to watch our Sp drop further .

Thanks frank . I think of yourgene as our little cousin who looks up to and tries to emulate his well travelled , highly successful , but massively understated uncle Novacyt .

If they are doing well , we will be doing very well .

No k , my twitter is same as my LSE moniker . Think I’ve followed you a while ago as I did a few other prominent posters on here .

Maybe you can check if there are couple of Bentleys in the directors parking spaces @ Hans ;)
Novacyt made a very wise acquisition with it is . We don’t know what the certain manufacturing criteria was Karean but I’m sure none of the share holders would mind them receiving their bonuses as long as they were selling shedloads of marsh mellows .

The initial consideration of £10.1 million will be reduced by £3.6 million of cash on the balance sheet of IT-IS at completion resulting in net cash consideration of £6.5 million. In addition, an earn out of up to £1.9 million in cash is payable to the directors of IT-IS over the next two years, subject to certain manufacturing targets being achieved

The it -is directors were also promised bonuses if they hit their manufacturing targets . I wonder if they have hit them yet ?

Your damn right the excitement has gone now @scotty.
I’m holding for results and looking at the covid cases in the U.K. and the world and the demand for PCR testing I am expecting good results.

Porky , I feel your pain , I remember been 60 k up in this with a lot less initially invested as I am now .
If I had spare funds would I top up ?
NO.
Far too much uncertainty and lack of information from the company to attract PI and the ****ty brokers we have paid for haven’t done jack in getting considerable institutions invested either .
I’ve said it before but I fully believe strings are been pulled and orders are been given from much higher powers than the ghost DA.
I believe he is just a pawn put in place until the full chess game is played out .

Sonic boom boy desperate for a lower re entry point are we ;)

Well worth reading about the future of diagnostics and future self testing for health .

https://twitter.com/boy_cellar/status/1481536935243956225?s=21

That is the £54 million dollar question exmex ;)

Great subject heading @ Karen . Thanks for bringing it to the boards attention.
;)

France allowing vaccinated in as long as they have a negative PCR test .
Note PCR not LFT .
Not sure about tata @welsh . There are photos of our q machines in use but they produce the tests in India and aren’t ours .
No one know for sure as Novacyt don’t share information with its shareholders ;)